Ernesto Bosch, M. D. , Elena Labarta, M. D

Slides:



Advertisements
Similar presentations
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Advertisements

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis  George Griesinger, M.D.,
A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage.
Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage 
Age at menarche: a predictor of diminished ovarian function?
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis 
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis  Ioannis P. Kosmas, M.D.,
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Initial experience with a risk-sharing in vitro fertilization–embryo transfer program with novel features  Jacques P. Stassart, M.D., Romaine B. Bayless,
Aviad Cohen, M.D., Benny Almog, M.D., Togas Tulandi, M.D., M.H.C.M. 
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Primary hyperparathyroidism in pregnancy
Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation  Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis  Cui Hong Zheng, M.D., Ph.D.,
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
I. Dimitriadis, G. Y. Christou, K. A. Dickinson, M. Thatcher, C. L
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Effect of Salpingectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis  C.E. Boots, MD, E.A. Seidler, MD, A. Ainsworth, MD, A. Hardi, MLIS,
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement    Fertility and Sterility  Volume 102,
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis  Dimitra Kyrou,
From partner's desk to iPad
Fertility and Sterility
What are patients doing with their mosaic embryos
Mark A. Zakaria, M. D. , Mazen E. Abdallah, M. D. , Valerie I
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Tiffany D. Justice, M.D., Steven T. Nakajima, M.D. 
Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer  Shokichi Teramoto,
Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles  Laura Detti, M.D.,
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Poor sperm quality affects clinical outcomes of intracytoplasmic sperm injection in fresh and subsequent frozen–thawed cycles: potential paternal effects.
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
A. Criniti, G. Chow, A. Khabani, L. Scott, N.A. Klein 
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone.
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Fertility and Sterility
A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Bruce S Shapiro, M. D. , Kevin S Richter, Ph. D. , Dee C Harris, M. T
S. Samuel Kim, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Failed IVF cycles and the risk of subsequent preeclampsia or fetal growth restriction: a case-control exploratory study  Ioanna Tsoumpou, M.D., Ahmed.
Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization  Efstratios M Kolibianakis, M.D., Kostas.
Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis  Ernesto Bosch, M.D., Elena.
A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer  William M. Buckett, M.D.  Fertility and Sterility 
Fertility and Sterility
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles  Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Fertility and Sterility
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Presentation transcript:

Regimen of ovarian stimulation affects oocyte and therefore embryo quality  Ernesto Bosch, M.D., Elena Labarta, M.D., Efstratios Kolibianakis, M.D., Mitchell Rosen, M.D., David Meldrum, M.D.  Fertility and Sterility  Volume 105, Issue 3, Pages 560-570 (March 2016) DOI: 10.1016/j.fertnstert.2016.01.022 Copyright © 2016 Terms and Conditions

Figure 1 Risk difference (RD) for clinical pregnancy (11% higher) between patients treated with FSH and GH and those treated with FSH only. Fertility and Sterility 2016 105, 560-570DOI: (10.1016/j.fertnstert.2016.01.022) Copyright © 2016 Terms and Conditions

Figure 2 Risk difference (RD) for the proportion of patients reaching ET (14% higher) between those treated with FSH and GH and those treated with FSH only. Fertility and Sterility 2016 105, 560-570DOI: (10.1016/j.fertnstert.2016.01.022) Copyright © 2016 Terms and Conditions